LMC advice over the prescribing of Continuous Glucose Monitoring (CGM) in Type 2, - SURREY HEARTLANDS

The prescribing of Continuous Glucose Monitoring (CGM) in Type 2 diabetes has been updated in NICE guidance, and the ICB have recently sent out a communication to all practices. The ICB have confirmed that there has been no implementation funding from NHS England, and the ICB position is that there is not sufficient resource for it to be included in the LCS. 

The LMC can confirm that there is no contractual requirement to implement this new application of monitoring in Primary Care, and the ICB have confirmed that referrals to Secondary Care for this treatment will be accepted. Practices should be aware that, since there is no contractual arrangement for provision of this service, it is our understanding that CNSGP may not cover this specialist work.

About this page

Updated on Thursday 19 December 2024

313 views